Where care and collaboration meet,
to make a difference when it matters most
Therapy Areas
We have a wide range of expertise across therapeutic areas which include cancer pain and asthma.
Asthma inhaler technique & training
Dr Stephanie Korn covers "inhaler technique & training" in this video.
Webinar & Videos
Upcoming Webinar
Introducing ▼REZZAYO® rezafungin, the first once weekly echinocandin....
Introducing REZZAYO® rezafungin, the first once weekly echinocandin....
Introducing REZZAYO® (rezafungin), the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 With a renowned faculty of Professor Oliver Cornely, Professor Tihana Bicanic and Professor Matteo Bassetti.
References
1. REZZAYO® (rezafungin). Summary of Product Characteristics. Napp 2024.
Agenda
19:00-20:00 BST
- Key challenges in the management of invasive candidiasis
- The data from the REZZAYO® clinical trial programme
- The potential benefits of REZZAYO® in the ICU, ward and for the outpatient
- Q&A
®: FLUTIFORM is the Trademark of Jagotec AG used under licence by Mundipharma.